The @CatoInstitute is the world's leading voice for individual rights in health and medicine. Sign up for the #CatoHealth newsletter at https://xitter.cf/t.co/xqhdtbdxg3

Washington, DC
Joined September 2018
📈Kentucky premiums jumped 30 percent this year, with 19 percent more planned for 2027. @mfcannon argues that the state's legislature can offer relief without spending a dime by letting residents buy plans from US territories. Read more: kentuckylantern.com/2026/10/…
1
5
561
The FDA's monopoly on drug approval produces what all monopolies do: high costs and limited access. Recognizing safety certifications from other countries would give Americans access to medicines already available to patients around the world — at lower prices, explain Cato’s @mfcannon and @dr4liberty. Learn more: ow.ly/YaX850Zll99
1
7
1
21
2,967
The health care industry is so good at regulatory capture, low-quality hospitals in South Florida literally used a consumer-protection law to protect poor-performing hospitals from consumers. cato.org/multimedia/media-hi… @LeapfrogGroup @CatoHealth
4
1
6
3,326
If Congress won't strip the FDA of its prescription power entirely, it should at least set an expiration date on prescription requirements, say Cato’s @mfcannon and @dr4liberty. Greater over-the-counter access would reduce the price of medicines. Check out Cato’s Handbook on Affordability to learn more about how to make health care more affordable: ow.ly/4Vzg50Zllyt
8
20
2,905
Licensing prevents lower-price clinicians from providing services they are competent to provide, explain Cato’s @mfcannon and @dr4liberty. The fix is simple: free nurse practitioners, psychologists, and pharmacists to practice to the full extent of their training. Prices drop, not quality. Check out Cato’s Handbook on Affordability to learn more: ow.ly/75Rk50ZllIV
1
7
11
4,148
CatoHealth retweeted
Click on the link below to hear Thursday’s show featuring the Florida Citizens Alliance CEO Keith Flaugh, Cato Institute’s Michael Cannon, CEI Senior Economist Ryan Young, and former Congressman and Ambassador Francis Rooney. dropbox.com/scl/fi/9dnzi00sz…
1
42
The FDA's monopoly on drug approval produces what all monopolies do: high costs and limited access. Recognizing safety certifications from other countries would give Americans access to medicines already available to patients around the world — at lower prices, explain Cato’s @mfcannon and @dr4liberty. Learn more: ow.ly/stWS50ZlkrX
4
18
1
33
2,969
Subsidies cannot solve the health care affordability problem. They help sustain it. Rather than create more government subsidies, policymakers should end supply-side regulations that reduce competition and increase prices. Cato’s @mfcannon and @dr4liberty propose immediate, supply-side policy changes that would broaden choice and improve affordability. Check out the Cato Institute Handbook on Affordability: ow.ly/QR8R50Z6R6z
1
11
1
22
1,903
Short-term health plans can cost up to 66% less than the cheapest Obamacare plan because they're exempt from its costliest regulations. Trump's 2018 rule proved this relief works—and that the next president can undo such a regulation. Congress should make Trump’s 2018 rule permanent, notes Cato’s @mfcannon. ow.ly/gTF550Z8VTu
11
1
12
3,108
With Medicaid fraud rampant and health care affordability making headlines, policymakers must take action to reduce health care costs. Cato's @RominaBoccia and @mfcannon took the conversation to Capitol Hill, examining Medicaid's flaws and making the case for fundamental reform.
1
5
11
2,782
Okay, this I wanna see.
Please join us on Thursday, June 25th, from 1:30 to 2:30pm for the inaugural HHS Health Economics and Policy Forum. HHS Affordability Czar Dr. Casey Mulligan will deliver a public lecture on supply-side health economics, and Dr. Oz will present. RSVP: aspe.hhs.gov/events/hhs-aspe…
1
1
1
10
2,463
In oncology, higher doses often come with more side effects but are not more effective. CMS pays for excessive doses of these drugs, damaging the health of patients and the finances of the government. It need not be this way. 🧵 1/5
2
3
212
According to the authors: “Given the unsustainable rise in this country’s health care spending, it is critical that legislators, regulators, payers, prescribers, and patients consider opportunities to reduce health care spending beyond simple price negotiations or controls.” 4/5
1
1
123
To tackle this issue, the authors have convened a meeting: "Novel Solutions to Address the Rising Cost of Oncology Drugs: Targeting the Demand Side." The event will take place on March 4-5 and is open to the public -@mfcannon You can register online: cpt.uchicago.edu/program/
2
96